Nagendran Sukumar bought TSHA

January 12, 2026 · Form 4 insider transaction

Nagendran Sukumar bought 88,676 shares of Taysha Gene Therapies, Inc. at $1.71 per share, a transaction worth $151.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.